{
    "title": "Novartis CAR-T therapy leads to durable response in lymphoma study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5164771/Novartis-CAR-T-therapy-leads-durable-response-lymphoma-study.html",
    "date": "2017-12-10",
    "keywords": [
        "treatment",
        "cancer",
        "kymriah",
        "novartis",
        "response",
        "study",
        "bill",
        "berkrot",
        "type",
        "meeting",
        "lymphoma",
        "percent",
        "sign",
        "cart",
        "schuster",
        "chemotherapy",
        "return",
        "time",
        "form",
        "blood",
        "immunotherapy",
        "sunday",
        "followup",
        "diffuse",
        "bcell",
        "meaning",
        "society",
        "hematology",
        "atlanta",
        "remission",
        "dr",
        "stephen",
        "investigator",
        "pilot",
        "class",
        "therapy",
        "engineering",
        "technology",
        "cant",
        "amount",
        "satisfaction",
        "excitement",
        "price",
        "august",
        "age",
        "leukemia",
        "market",
        "approval",
        "dlbcl",
        "stem",
        "cell",
        "half",
        "turnaround",
        "patient",
        "analysis",
        "duration",
        "disease",
        "progression",
        "release",
        "syndrome",
        "side",
        "end",
        "year",
        "reporting",
        "zieminski"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}